Cleopatra Hospital is trading 3.17% lower at $13.45, with no specific cause established for the October 22, 2026 decline.
- A recent company disclosure concerned approval of a share-capital increase for employee incentive plans. A reference price is scheduled for October 27, but reporting does not link the disclosure to the move.
- Supplied U.S. indices were lower, while a market report showed Egypt’s EGX 30 higher on October 22.